Copyright Reports & Markets. All rights reserved.

Global Atypical Antipsychotic Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Atypical Antipsychotic Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Risperidone
      • 1.2.2 Olanzapine
      • 1.2.3 Quetiapine
      • 1.2.4 Ziprasidone
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Bipolar I Disorder
      • 1.3.2 Schizophrenia
      • 1.3.3 Schizoaffective Disorder
      • 1.3.4 Major Depressive Disorder (MDD)
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Novartis AG
      • 2.1.1 Business Overview
      • 2.1.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novartis AG Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Bristol-Myers Squibb Company
      • 2.2.1 Business Overview
      • 2.2.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Allergan
      • 2.3.1 Business Overview
      • 2.3.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Allergan Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Cardinal Health
      • 2.4.1 Business Overview
      • 2.4.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Cardinal Health Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 GlaxoSmithKline
      • 2.5.1 Business Overview
      • 2.5.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 GlaxoSmithKline Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Johnson and Johnson
      • 2.6.1 Business Overview
      • 2.6.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Johnson and Johnson Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Eil Lilly and Company
      • 2.7.1 Business Overview
      • 2.7.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Eil Lilly and Company Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Pfizer
      • 2.8.1 Business Overview
      • 2.8.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Pfizer Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Sanis Health
      • 2.9.1 Business Overview
      • 2.9.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Sanis Health Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Sun Pharmaceutical Industries
      • 2.10.1 Business Overview
      • 2.10.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 AstraZeneca
      • 2.11.1 Business Overview
      • 2.11.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 AstraZeneca Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Sumitomo Dainippon Pharma
      • 2.12.1 Business Overview
      • 2.12.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Qilu Pharmaceutical
      • 2.13.1 Business Overview
      • 2.13.2 Atypical Antipsychotic Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Atypical Antipsychotic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Atypical Antipsychotic Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Atypical Antipsychotic Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Atypical Antipsychotic Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Atypical Antipsychotic Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Atypical Antipsychotic Drugs Market Analysis by Regions

    • 4.1 Global Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Atypical Antipsychotic Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Atypical Antipsychotic Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    5 North America Atypical Antipsychotic Drugs by Country

    • 5.1 North America Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Atypical Antipsychotic Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Atypical Antipsychotic Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    6 Europe Atypical Antipsychotic Drugs by Country

    • 6.1 Europe Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Atypical Antipsychotic Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Atypical Antipsychotic Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Atypical Antipsychotic Drugs by Country

    • 7.1 Asia-Pacific Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Atypical Antipsychotic Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Atypical Antipsychotic Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    8 South America Atypical Antipsychotic Drugs by Country

    • 8.1 South America Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Atypical Antipsychotic Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Atypical Antipsychotic Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Atypical Antipsychotic Drugs by Countries

    • 9.1 Middle East and Africa Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Atypical Antipsychotic Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Atypical Antipsychotic Drugs Sales and Growth Rate (2014-2019)

    10 Global Atypical Antipsychotic Drugs Market Segment by Type

    • 10.1 Global Atypical Antipsychotic Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Atypical Antipsychotic Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Atypical Antipsychotic Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Risperidone Sales Growth and Price
      • 10.2.1 Global Risperidone Sales Growth (2014-2019)
      • 10.2.2 Global Risperidone Price (2014-2019)
    • 10.3 Olanzapine Sales Growth and Price
      • 10.3.1 Global Olanzapine Sales Growth (2014-2019)
      • 10.3.2 Global Olanzapine Price (2014-2019)
    • 10.4 Quetiapine Sales Growth and Price
      • 10.4.1 Global Quetiapine Sales Growth (2014-2019)
      • 10.4.2 Global Quetiapine Price (2014-2019)
    • 10.5 Ziprasidone Sales Growth and Price
      • 10.5.1 Global Ziprasidone Sales Growth (2014-2019)
      • 10.5.2 Global Ziprasidone Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Atypical Antipsychotic Drugs Market Segment by Application

    • 11.1 Global Atypical Antipsychotic Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Bipolar I Disorder Sales Growth (2014-2019)
    • 11.3 Schizophrenia Sales Growth (2014-2019)
    • 11.4 Schizoaffective Disorder Sales Growth (2014-2019)
    • 11.5 Major Depressive Disorder (MDD) Sales Growth (2014-2019)

    12 Atypical Antipsychotic Drugs Market Forecast (2019-2024)

    • 12.1 Global Atypical Antipsychotic Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Atypical Antipsychotic Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Atypical Antipsychotic Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Atypical Antipsychotic Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Atypical Antipsychotic Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Atypical Antipsychotic Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Atypical Antipsychotic Drugs Market Forecast (2019-2024)
    • 12.3 Atypical Antipsychotic Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Atypical Antipsychotic Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Atypical Antipsychotic Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Atypical Antipsychotic Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Atypical Antipsychotic Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Atypical Antipsychotic Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Atypical Antipsychotic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Atypical Antipsychotic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Novartis AG
      Bristol-Myers Squibb Company
      Allergan
      Cardinal Health
      GlaxoSmithKline
      Johnson and Johnson
      Eil Lilly and Company
      Pfizer
      Sanis Health
      Sun Pharmaceutical Industries
      AstraZeneca
      Sumitomo Dainippon Pharma
      Qilu Pharmaceutical

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Risperidone
      Olanzapine
      Quetiapine
      Ziprasidone
      Others

      Market Segment by Applications, can be divided into
      Bipolar I Disorder
      Schizophrenia
      Schizoaffective Disorder
      Major Depressive Disorder (MDD)

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Atypical Antipsychotic Drugs product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Atypical Antipsychotic Drugs, with price, sales, revenue and global market share of Atypical Antipsychotic Drugs in 2017 and 2018.
      Chapter 3, the Atypical Antipsychotic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Atypical Antipsychotic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Atypical Antipsychotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Atypical Antipsychotic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
      Buy now